Question 1

What is the catalog number for CD105, ID (E395) (ENG, END, Endoglin, CD105) (MaxLight 550) discontinued?

Accepted Answer

The catalog number for CD105, ID (E395) (ENG, END, Endoglin, CD105) (MaxLight 550) discontinued is 033445-ML550.

Question 2

What sizes are available for CD105, ID (E395) (ENG, END, Endoglin, CD105) (MaxLight 550) discontinued?

Accepted Answer

CD105, ID (E395) (ENG, END, Endoglin, CD105) (MaxLight 550) discontinued is available in the following size(s): 100 µL.

Question 3

Is CD105, ID (E395) (ENG, END, Endoglin, CD105) (MaxLight 550) discontinued in stock?

Accepted Answer

CD105, ID (E395) (ENG, END, Endoglin, CD105) (MaxLight 550) discontinued is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What is the difference between this product and a similar catalogue number?

Accepted Answer

Differences typically involve clone, conjugate, host species, or validated applications. Compare the respective datasheets, or contact us with both catalogue numbers for a direct comparison.

Question 5

Do you offer custom or private-label production of this type of product?

Accepted Answer

Yes, custom antibody development and private-label production services are available. Contact our sales team to discuss your target, timeline, and quantity requirements.

Question 6

What is the immunogen used to generate this antibody?

Accepted Answer

Immunogen or antigen details used to raise this antibody are listed on the product datasheet under immunogen information.

CD105, ID (E395) (ENG, END, Endoglin, CD105) (MaxLight 550) discontinued

Product Specifications

Clonality

Frequently Asked Questions

Explore Other Products

2,3-O-Cyclohexylidene-b-D-ribofuranose

Alpha SNAP (NAPA) (NM_003827) Human Over-expression Lysate

HSV1 (Herpes Simplex Virus Type I) (HSV1/1934), Biotin conjugate, 0.1mg/mL

1,4-bis(7-Chloroquinolin-4-yl)piperazine

Caldesmon, HMW (h-Caldesmon) (CALD1/820), Biotin conjugate, 0.1mg/mL

EGFRvIII (Epidermal Growth Factor Receptor, Variant III) (GFR/2600R), CF405S conjugate, 0.1mg/mL